1. Home
  2. GNFT vs NATR Comparison

GNFT vs NATR Comparison

Compare GNFT & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • NATR
  • Stock Information
  • Founded
  • GNFT 1999
  • NATR 1972
  • Country
  • GNFT France
  • NATR United States
  • Employees
  • GNFT 167
  • NATR N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • NATR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNFT Health Care
  • NATR Health Care
  • Exchange
  • GNFT Nasdaq
  • NATR Nasdaq
  • Market Cap
  • GNFT 189.6M
  • NATR N/A
  • IPO Year
  • GNFT 2019
  • NATR N/A
  • Fundamental
  • Price
  • GNFT $3.80
  • NATR $15.00
  • Analyst Decision
  • GNFT Strong Buy
  • NATR Strong Buy
  • Analyst Count
  • GNFT 1
  • NATR 2
  • Target Price
  • GNFT $13.00
  • NATR $19.50
  • AVG Volume (30 Days)
  • GNFT 9.8K
  • NATR 42.4K
  • Earning Date
  • GNFT 09-19-2024
  • NATR 11-07-2024
  • Dividend Yield
  • GNFT N/A
  • NATR N/A
  • EPS Growth
  • GNFT N/A
  • NATR 114.95
  • EPS
  • GNFT 0.47
  • NATR 0.88
  • Revenue
  • GNFT $86,225,222.00
  • NATR $445,095,000.00
  • Revenue This Year
  • GNFT $155.44
  • NATR $2.07
  • Revenue Next Year
  • GNFT N/A
  • NATR $2.62
  • P/E Ratio
  • GNFT $7.59
  • NATR $17.44
  • Revenue Growth
  • GNFT 175.45
  • NATR 1.36
  • 52 Week Low
  • GNFT $3.31
  • NATR $10.81
  • 52 Week High
  • GNFT $6.42
  • NATR $21.72
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 29.24
  • NATR 42.45
  • Support Level
  • GNFT $3.63
  • NATR $14.90
  • Resistance Level
  • GNFT $3.88
  • NATR $15.88
  • Average True Range (ATR)
  • GNFT 0.10
  • NATR 0.62
  • MACD
  • GNFT 0.02
  • NATR -0.21
  • Stochastic Oscillator
  • GNFT 15.30
  • NATR 5.24

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: